CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Fortress Biotech Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Fortress Biotech Inc
1111 KANE CONCOURSE, SUITE 301
Phone: (781) 652-4500p:781 652-4500 BAY HARBOR ISLANDS, FL  33154  United States Ticker: FBIOFBIO

Business Summary
Fortress Biotech, Inc. is a biopharmaceutical company that acquires, develops and commercializes pharmaceutical and biotechnology products and product candidates. The Company markets its various branded dermatology products, Qbrexza, Accutane, Amzeeq, Zilxi, Ximino, Exelderm and Targadox. Qbrexza (glycopyrronium 2.4%) is a medicated cloth towelette for the treatment of primary axillary hyperhidrosis in adults and children nine years and older. Accutane (isotretinoin) is an oral capsule for the treatment of severe recalcitrant nodular acne. Amzeeq (minocycline 4%) topical foam is a topical minocycline treatment for the inflammatory lesions of non-nodular moderate to severe acne vulgaris in adults and children nine years and older. Zilxi (minocycline 1.5%) is a topical foam and a topical minocycline treatment for inflammatory lesions of rosacea in adults. Ximino (minocycline hydrochloride) is an oral minocycline drug for the treatment of moderate to severe acne.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202312/31/2022YesYes--Yes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Executive Chairman of the Board, President, Chief Executive Officer Lindsay A.Rosenwald 67 12/19/2013 10/1/2009
Co-Vice Chairman of the Board Eric K.Rowinsky 66 12/31/2015 10/1/2010
Chief Financial Officer, Corporate Secretary DavidJin 33 8/16/2022 8/16/2022
7 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Journey Medical Corp 9237 E Via De Ventura Blvd. SCOTTSDALE AZ United States
Avenue Therapeutics Inc 1111 KANE CONCOURSE, SUITE 301 BAY HARBOR ISLANDS FL United States
Checkpoint Therapeutics Inc 95 SAWYER ROAD, SUITE 110 WALTHAM MA United States
3 additional Subsidiary records available in full report.

Business Names
Business Name
Aevitas Therapeutics, Inc.
Avenue Therapeutics, Inc.
Baergic Bio, Inc.
16 additional Business Names available in full report.

General Information
Number of Employees: 187 (As of 12/31/2022)
Outstanding Shares: 18,376,750 (As of 1/3/2024)
Shareholders: 433
Stock Exchange: NASD
Federal Tax Id: 205157386
Fax Number: (781) 652-4545
Email Address: info@coronadobio.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, March 28, 2024